At the 2022 ACHEMA conference we had the pleasure of getting to talk to Slim Chiha, CEO and founder of Prosion Therapeutics who was participating in the Start-Up Challenge Award.
PROSION is a Biotech and drug development company based in Germany that aims at making the undruggable druggable. Through a proprietary platform technology of LEGO-like chemical building blocks, they are able to develop new and effective drugs, targeting hard-to-treat diseases - starting with the most aggressive cancer forms.
Hear what Slim has to say about:
How he came to be working with Prosion
The challenges of scaling up drug candidates
The biggest development he's seen in the industry so far
About Slim Chiha
Slim has a Ph.D. in Chemistry and a special interest in drug development. He co-founded and is CEO of a biotech startup that holds the Seal of Excellence of the European Commission. Previously he has experience as a medicinal chemist in a publicly funded oncology project and trained at a global pharmaceutical company.
The Bio-Works staff are seasoned and enthusiastic (yes, even a bit nerdy) experts in purification resins, methods and strategies with many years of experience of the ins and outs of this field. We love our job and we’d love to help you do yours by sharing some good solid facts, principles and best practice. In short – “purification made simple”.